肝硬化住院患者中的慢性肾病:全球视角研究
基于全球127个中心前瞻性 enrolled 的7040例非择期入院肝硬化患者,评估慢性肾病(CKD)的全球患病率及其对预后的影响。结果显示CKD全球患病率为18.17%,高收入国家最高;CKD+患者腹水更常见(76.5% vs 61.1%),院内AKI发生率更高(59.4% vs 27%),且与更高的院内及出院后30天死亡率相关。
要点
- 肝硬化住院患者中CKD全球患病率为18.17%,高收入国家最高。
- CKD+患者腹水发生率76.5%,显著高于CKD-患者的61.1%。
- CKD+患者院内AKI发生率59.4%,显著高于CKD-患者的27%。
核心结论
- CKD的存在对全球肝硬化住院患者的预后产生负面影响。
- 精细的腹水管理和生活方式改变,尤其在高收入国家,可能改善这些患者的结局。
研究设计与样本
- 慢性肝病演变与事件及失代偿登记联盟前瞻性 enrolled 全球127个中心的非择期入院肝硬化患者,每个中心最多100例。
- 共纳入7040例住院患者,收集人口学、合并症、肝硬化病史、住院经过和结局,分为CKD+与CKD-组比较,并按世界银行收入分层比较。
主要发现
- 全球CKD患病率为18.17%,高收入国家患病率最高,与其代谢综合征患病率较高平行。
- CKD+患者入组时中位GFR为32(21,44)mL/min/1.73 m2,CKD-患者为88(63,117)mL/min/1.73 m2(p<0.0001)。
- CKD+患者腹水发生率76.5%,CKD-患者为61.1%(p<0.0001)。
- CKD+患者院内AKI发生率59.4%,CKD-患者为27%(p<0.0001)。
- CKD与更高的院内死亡率和出院后30天死亡率相关(均p<0.0001)。
临床怎么用
- 对肝硬化住院患者应评估CKD状态,CKD+者腹水和AKI风险更高,需更精细管理腹水并关注肾功能。
- 高收入国家尤其应重视代谢综合征相关因素及生活方式干预以改善预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prevalence of chronic kidney disease (CKD), defined as a glomerular filtration rate (GFR) of <60 mL/min/1.73 m2 for >3 months, is rising in the global population. OBJECTIVE: To assess the global prevalence of CKD in cirrhosis and how it impacts the prognosis of these patients. DESIGN: The Chronic Liver Disease Evolution and Registry for Events and Decompensation consortium prospectively enrolled non-electively admitted cirrhosis patients from 127 sites globally, each with up to 100 patients. Data collected were demographics, comorbid conditions, cirrhosis history, hospital course and patient outcomes. Patients were divided into those with (CKD+) and without CKD (CKD-) and compared. We also compared patients from different World Bank income strata. RESULTS: Of 7040 inpatients enrolled, the global prevalence of CKD was 18.17%, with the highest prevalence observed in high-income countries (HICs), which paralleled their higher prevalence of metabolic syndrome. CKD+ patients had lower median enrolment GFR (32 (21, 44) mL/min/1.73 m2) when compared with CKD- patients (88 (63, 117) mL/min/1.73 m2, p<0.0001), associated with a more complex history of cirrhosis complications, with ascites occurring in 76.5% of CKD+ versus 61.1% of patients with CKD- (p<0.0001). The most common in-hospital complication was the development of AKI (59.4%) in CKD+ versus 27% in CKD- patients (p<0.0001). CKD was associated with higher in-hospital and 30-day postdischarge mortality (both p<0.0001). CONCLUSIONS: The presence of CKD negatively impacts the prognosis of admitted patients with cirrhosis in a global cohort. Meticulous management of ascites and lifestyle changes, especially in HICs, may improve the outcome of these patients.
引用
- Wong F, Adebayo D, George J, et al. Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective. Gut. 2026. PMID: 42248676. doi:10.1136/gutjnl-2025-336802
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。